Latest Breaking News On - Damien mcdevitt - Page 4 : comparemela.com

Aspen Neuroscience Raises $147 5M in Series B Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

San diegoUnited statesAl iskandariyahDamien mcdevittDoug fisherAspen neuroscience incFrazier life sciencesAspen neuroscienceRevelation partnersNewton investment managementLifeforce capitalMedical excellence capital partnersMirae asset capitalAlexandria ventureScreening cohort

Aiming to treat Parkinson s by replacing neurons, Aspen Neuroscience nabs $147M

Aspen Neurosciences is developing a cell therapy that uses a patient’s own stem cells to develop a personalized treatment for Parkinson’s disease. The approach is slightly different than that of Bayer, whose experimental Parkinson’s cell therapy is made from stem cells sourced from healthy donors.

Al iskandariyahDamien mcdevittBayer parkinsonChristian rommelBluerock parkinsonAspen neurosciencesFrazier life sciencesSan diego basedLike aspenBluerock therapeuticsVersant venturesMedcity newsHealth care conferenceNewton investment managementLifeforce capitalMedical excellence capital partners

Aspen Neuroscience Announces $147 5 Million Series B Financing, Led by GV, LYFE Capital and Revelation Partners

Will Fund Clinical Trials of Company s First iPSC-derived Autologous Dopamine Neuron Replacement for Parkinson s DiseaseSAN DIEGO, May 9, 2022 /PR.

United statesSan diegoAl iskandariyahFaheem hasnainDamien mcdevittDoug fisherFund clinical trials of company firstAspen neuroscience incFrazier life sciencesWill fund clinical trialsAutologous dopamine neuron replacementAspen neuroscienceRevelation partnersNewton investment managementLifeforce capitalMedical excellence capital partners

New Clinical Trial of Cell Replacement in Parkinson s Disease

Aspen Neuroscience, Inc. announced that this month it will launch the first patient screening study of its kind, working with multiple clinical screening

United statesDamien mcdevittAspen neuroscience incUs food drug administrationAspen neuroscienceTrial ready cohort studyInvestigational new drugDrug administration

Aspen to commence screening study for Parkinson s disease treatment

Aspen to commence screening study for Parkinson s disease treatment
clinicaltrialsarena.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from clinicaltrialsarena.com Daily Mail and Mail on Sunday newspapers.

Damien mcdevittLife sciences companiesDrug administrationTranslation services forAspen neuroscienceTrial ready cohort studyInvestigational new drugLife sciencesRegulatory consultation